Product Description :
Locula is an ophthalmic preparation of sulphacetamide sodium for the treatment of common inflammatory disorders of the eye
Sulphacetamide sodium (Locula) has remarkable fungistatic activity against Aspergillus, Candida albicans, Penicillium chrysogenum, Curvalaria lunata responsible for corneal infections. Sulphacetamide penetrates readily into aqueous humour and ocular tissues in high concentrations
Locula is useful in the management of conjunctivitis, iritis, corneal ulcer, ophthalmia neonatorum, blepharitis and other superficial ocular infections due to susceptible microorganisms.
Hypersensitivity to sulphonamides.
There may be local irritation, transient stinging or burning with 30% solution. Sensitivity reactions are rare.
Locula is incompatible with silver preparations. Non-susceptible organisms may proliferate with the use of sulphonamide preparations. Sulphonamides are inactivated by para-aminobenzoic acid present in purulent exudates. Sensitization and
cross-sensitivity between different sulphonamides may occur. On development of signs of sensitivity or untoward reactions use of Locula should be discontinued
Dosage & Administration
2 drops of Locula to be instilled into the conjunctival sac every 2 hours initially. The time interval may be increased as the condition responds. 10% or 20% solutions for mild and chronic infections and 30% solution for acute and severe cases.
Locula 10%, Locula 20%, Locula 30%
Dropper vials 10 ml
Additional Information :
Year of Establishment|
Nature of Business|
Manufacturer, Wholesaler, Service Provider
Number of Employees|
More than 1000 People
Rs. 50 - 100 Crore ( or US$ 10 Mn - 20 Mn Approx.)
On April 27, 1936, East India Pharmaceutical Works Limited, one of the oldest pharmaceutical companies in India, was born. It started with the extraordinary vision of an extraordinary man, Late Ashoke Kumar Sen. Few years later, another visionary and also an extraordinary man, Late Hirendranath Dutt Gupta joined Late Ashoke Kumar Sen and led the company towards its present heights.
The object was simple - to develop, through private entrepreneurship, an organization to synthesize modern drugs from basic chemicals and cater to the needs of the millions.
Depending solely on national resources and talents - East India Pharmaceutical Works Limited ( EIPWL ) now has emerged as a large pharmaceutical company with three manufacturing units, workforce of 1500 employees and an annual turnover of around Rs.800 million.With forward looking ideas, R&D orientation, quality consciousness and a strong financial fundamental, East India Pharmaceutical Works Limited is determined to open up new horizons.
East India Pharmaceutical Works Limited
6,Nandalal Bose Sarani
Kolkata - 700071 West Bengal, India